SAN DIEGO, March 5, 2001 (PRIMEZONE) -- Women First HealthCare, Inc. (Nasdaq:WFHC) today announced that Edward F. Calesa, chairman, president and CEO, will present at the Salomon Smith Barney (SSB) 1st Annual Specialty Pharmaceuticals Conference. The conference will be held March 8-9, 2001 at the Grand Hyatt in New York City.
Mr. Calesa's presentation is scheduled for Friday, March 9, 2001, from 1:30 - 2:00 PM Eastern Time (Ballroom E) and will include discussion of business operations, improved fourth quarter and year-end 2000 results, and strategic plans for the company.
The two-day conference will focus on companies of investment interest in the specialty pharmaceutical sector and feature over 40 leading brand-focused, generics and drug delivery specialty pharmaceutical firms.
Mr. Calesa's presentation at the SSB conference will be available to all interested parties through a live audio webcast (with slides) on March 9, 2001, 1:30 PM Eastern Time, at http://www.veracast.com/ssb_specialtypharmaceuticals2001/clientaccess/23211284.cfm. A link to the live audio webcast will also be provided on www.womenfirst.com, Investor Relations, Interviews/Presentations. The audio webcast will be archived for replay on the websites for thirty days until approximately April 6. Mr. Calesa's SSB slide presentation will be available on the Company's website by 1:30 p.m. Eastern Time on March 9 within the Investor Relations, Interviews/Presentations area.
About Women First HealthCare, Inc.
Founded in 1996, Women First HealthCare, Inc. is a San Diego-based specialty pharmaceutical company. Its mission is to help midlife women make informed choices regarding their health care needs and to provide pharmaceutical and lifestyle product solutions to meet those needs. Women First is specifically targeted to women age 40+ and their clinicians. The Company's Pharmaceutical Division, which includes a nationwide team of experienced sales specialists, contacts primarily OB/GYNs and Nurse Practitioners with estrogen replenishment options - ORTHO-EST(r) Tablets and Esclim(tm) (estradiol transdermal system). The Consumer Business is responsible for Daily Difference(tm) dietary supplements, developed in consultation with Tufts University School of Nutrition Science and Policy, and the Company's line of self-care products available through its As We Change(r) national mail order catalog and Internet retailer, www.aswechange.com. Trialogue(tm), the Corporate Marketing Division, is responsible for providing access to Women First's network of opinion leaders and clinicians through strategic marketing programs for sale to major pharmaceutical companies. The Company's business strategy includes the acquisition and licensing of additional prescription products that support its mission. Further information about Women First can be found online at www.womenfirst.com.